Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog studied for its interaction with GHRH receptors and endocrine signaling pathways.

Research involving Tesamorelin has examined GHRH receptor activation, pituitary somatotroph signaling, pulsatile growth-hormone-axis regulation, IGF-1-associated pathways, cellular metabolism, and neuroendocrine signaling. Its structural modification from native GHRH provides a research model for investigating peptide stability and GHRH-mediated receptor activity.

Tesamorelin remains an important compound for studying the relationship between GHRH signaling, pituitary biology, growth-factor pathways, and endocrine regulation.